gsk presentation 8th jan 2008, page-7

We will see whos right in February 2008. I base my numbers on all the research I have done. Remember the GSK quarter is done in arrears for delivered Relenza. If USA State deadline was End of November 2007 then it wont appear in FEB 7th Quarter results.

As you say each to their own but my research told me to sell all my holdings of BTA at $1.72.

Remember that was just before the result of the last GSK rsult when I predicted that massive decrease in orders.

BTA said it was seasonal when even GSK said in their statement it was from a drop in stockpiling orders.

I have a pretty good feel whos ordering what and when based on press releases and government files.